Information on the Target
Arda Biomaterials aims to revolutionize the leather alternatives market by converting brewery waste into a sustainable and biodegradable material, branded as New Grain™. This innovative approach utilizes spent barley grain from the beer brewing industry, a by-product that would otherwise be discarded or incinerated, to create an animal and plastic-free leather substitute suitable for various applications, including fashion, home goods, and automotive products.
The company was founded in 2022 by Edward TJ Mitchell and Brett Cotten, who met through Entrepreneur First, a global talent investor. With Edward holding a PhD in chemistry and Brett having extensive experience in the alternative protein sector, the duo is well-equipped to steer Arda towards its goal of developing environmentally friendly materials. Currently based in 'The Leather Market' near London Bridge, Arda is collaborating with local breweries along the historic 'Bermondsey Beer Mile' to source its raw materials.
Industry Overview in the UK
The fashion and retail industries in the UK are undergoing a significant transformation, driven by increasing consumer demand for sustainable and environmentally responsible products. As awareness of the environmental impact of traditional leather production grows, there is a compelling need for innovative alternatives that can reduce waste and carbon emissions. The market for vegan and eco-friendly materials is expanding rapidly, presenting an opportunity for companies like Arda to capture a share of this burgeoning sector.
The UK government has also prioritized sustainability, aiming for substantial reductions in waste and pollution through initiatives that promote a circular economy. This includes support for businesses that creatively utilize waste materials to replace conventional resources. Arda's innovative use of brewery waste aligns perfectly with this national agenda and highlights the potential for disruptive technologies in addressing environmental challenges within traditional industries.
Additionally, as the fashion industry grapples with the consequences of fast fashion and the harm it inflicts on the planet, brands are actively seeking alternatives that resonate with environmentally conscious consumers. Arda's product meets this demand for more sustainable solutions while maintaining desirable qualities typically found in leather. This alignment of market forces indicates robust potential growth for Arda in the coming years.
Overall, the UK market is ripe for the introduction of sustainable and innovative materials such as New Grain™, with favorable regulatory and consumer trends driving the need for change within the industry.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The recent £1.1 million investment in Arda Biomaterials, led by Clean Growth Fund, reflects the high market potential and innovative capabilities of the company. The investment not only provides the necessary capital for Arda to refine its production processes and bring New Grain™ to market but also underlines the growing recognition for sustainable solutions in industries historically reliant on environmentally damaging practices.
This funding round, which includes participation from multiple investors with expertise in alternative protein, fashion, and climate tech, is a strong endorsement of Arda's vision. The financing will accelerate the development of its product and enable the company to fulfill its mission of producing a biodegradable and sustainable leather alternative, which is increasingly attractive to brands looking to enhance their sustainability profiles.
Information About the Investor
Clean Growth Fund is a prominent investment vehicle dedicated to supporting businesses and technologies that contribute to the reduction of carbon emissions and foster sustainable economic growth. By strategically investing in companies that offer pioneering solutions to environmental challenges, Clean Growth Fund aims to create measurable impacts while achieving attractive financial returns.
With a diverse portfolio encompassing various sectors, Clean Growth Fund seeks out innovative companies that can disrupt traditional practices and promote the transition to a low-carbon economy. The decision to invest in Arda Biomaterials underscores the fund's commitment to supporting breakthrough technologies that possess the potential to reform environmentally taxing industries, such as leather production.
View of Dealert
The investment in Arda Biomaterials presents a compelling opportunity within the sustainable materials landscape. The growing market for leather alternatives, particularly in the fashion and retail sectors, indicates a strong potential for New Grain™ to gain traction among brands seeking eco-friendly sourcing options.
Moreover, with increasing regulatory pressures and consumer expectations surrounding sustainability, the timing of this investment aligns perfectly with market trends. Arda's innovative approach to utilizing brewery waste not only addresses environmental concerns but also positions the company to capitalize on the depleting resources associated with traditional leather production.
Additionally, the expertise of founders Edward TJ Mitchell and Brett Cotten, along with the backing of experienced investors, adds a layer of credibility and strategic insight that could propel Arda toward successful commercialization. The imminent development of a market-ready product adds to the attractiveness of this opportunity, indicating solid prospects for growth and returns.
In conclusion, the investment in Arda Biomaterials by Clean Growth Fund appears to be a well-considered move with the potential for significant environmental benefits and financial upside, making it a highly favorable investment in the current landscape.
Similar Deals
Cambridge Innovation Capital, SV Health Investors’ Dementia Discovery Fund, M Ventures, Pfizer Ventures → TRIMTECH Therapeutics
2025
ACF Investors → Monument Therapeutics
2025
AlbionVC and Spark Capital → Latent Technology
2025
Clean Growth Fund
invested in
Arda Biomaterials
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $1M